Home›Trial›NCT07153146

🔬NCT07153146Phase 1RECRUITING

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.

Study Summary

The goal of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PN-881 in healthy adult participants.

Conditions

Healthy Volunteer

Interventions / Drugs

PN-881 Oral Solution PN-881 Oral Tablet Placebo

View on ClinicalTrials.gov ↗

Sponsor

Protagonist Therapeutics

Peptide Therapeutics

Study Details

Enrollment142 participants

Primary Completion—

Lead SponsorProtagonist Therapeutics, Inc.

Data Retrieved2026-04-11 04:25:05.763726+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.